John F. Sheridan
2020
In 2020, John F. Sheridan earned a total compensation of $3.8M as President and Chief Executive Officer at Tandem Diabetes Care, a 64% decrease compared to previous year.
Compensation breakdown
| Bonus | $60,385 |
|---|---|
| Non-Equity Incentive Plan | $422,692 |
| Option Awards | $1,619,976 |
| Salary | $600,000 |
| Stock Awards | $1,079,971 |
| Other | $7,715 |
| Total | $3,790,739 |
Sheridan received $1.6M in option awards, accounting for 43% of the total pay in 2020.
Sheridan also received $60.4K in bonus, $422.7K in non-equity incentive plan, $600K in salary, $1.1M in stock awards and $7.7K in other compensation.
Rankings
In 2020, John F. Sheridan's compensation ranked 3,031st out of 13,090 executives tracked by ExecPay. In other words, Sheridan earned more than 76.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,031 out of 13,090 | 77th |
Division Manufacturing | 1,182 out of 5,621 | 79th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 136 out of 799 | 83rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 74 out of 495 | 85th |
Industry Surgical and Medical Instruments and Apparatus | 49 out of 313 | 84th |
Source: SEC filing on April 13, 2022.
Sheridan's colleagues
We found four more compensation records of executives who worked with John F. Sheridan at Tandem Diabetes Care in 2020.